Fluge & Mella's pre-trial study highlights life-changing potential of rituximab
Sasha gives the background and Simon gives the interpretation of the latest study from Haukeland, published today...
Discuss the article on the Forums.

50% reduction in breast and prostate cancer in people with HIV on antiretrovirals

Discussion in 'XMRV Research and Replication Studies' started by Bob, Jun 2, 2011.

  1. jace

    jace Off the fence

    Messages:
    855
    Likes:
    172
    England
    1. Simard et al is the paper that Invitro refers to in his post. Unfortunately, access to the full paper is not available online, however I am sure that Stewart and Cameron did have access, and their Lancet piece is a commentary on, among other papers, Simard et al. So in answer to your questions, InVitro,
    in this instance, the abstract you posted gives the details of the cohort numbers but not the demographic of the cohort. However, I am sure, once again, that the full paper does. However, since breast cancer is now striking a younger group of women (as I know to my family's misfortune) the age of the cohort, in that case, may not be as revealing as you suggest.

    So you can see that the newer paper merely expands on the work of the one you have posted and others. A mini-meta analysis, if you like.

    The search goes on! That is all we ask, that the scientific research is allowed to continue, and John Coffin's call to put a stop to it is ignored.

    I like the balance shown in this paper.

    http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(11)70082-2/fulltext#back-bib8
     

See more popular forum discussions.

Share This Page